Administration de la santé publique : Questions médicales fréquentes
Nom anglais: Public Health Administration
Descriptor UI:D011635
Tree Number:N04.452.794
Termes MeSH sélectionnés :
Placenta
Questions fréquentes et termes MeSH associés
Diagnostic
2
#1
Comment évaluer l'efficacité d'un programme de santé publique ?
L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données.
Évaluation des programmesSanté publique
#2
Quels outils sont utilisés pour le diagnostic en santé publique ?
Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés.
ÉpidémiologieStatistiques de santé
Symptômes
2
#1
Quels symptômes indiquent un problème de santé publique ?
Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs.
ÉpidémiesMaladies infectieuses
#2
Comment les symptômes de maladies affectent-ils la santé publique ?
Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins.
Politiques de santéPrévention des maladies
Prévention
2
#1
Quelles stratégies de prévention sont efficaces ?
Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces.
Éducation à la santéCampagnes de vaccination
#2
Comment la prévention est-elle mesurée ?
Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages.
DépistagePrévention des maladies
Traitements
2
#1
Quels traitements sont prioritaires en santé publique ?
Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires.
VaccinationSanté maternelle
#2
Comment les traitements sont-ils administrés en santé publique ?
Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation.
Programmes de santéSensibilisation
Complications
2
#1
Quelles complications peuvent survenir sans intervention en santé publique ?
Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir.
Résistance aux antibiotiquesMaladies chroniques
#2
Comment les complications affectent-elles les systèmes de santé ?
Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel.
Systèmes de santéRessources en santé
Facteurs de risque
2
#1
Quels sont les principaux facteurs de risque en santé publique ?
Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés.
Comportements à risqueAccès aux soins
#2
Comment identifier les facteurs de risque dans une population ?
Par des études épidémiologiques, des enquêtes et des analyses de données démographiques.
Analyse démographiqueÉtudes épidémiologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Administration de la santé publique : Questions médicales les plus fréquentes",
"headline": "Administration de la santé publique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Administration de la santé publique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Organisation et administration",
"url": "https://questionsmedicales.fr/mesh/D009934",
"about": {
"@type": "MedicalCondition",
"name": "Organisation et administration",
"code": {
"@type": "MedicalCode",
"code": "D009934",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique",
"alternateName": "Public Health Administration",
"code": {
"@type": "MedicalCode",
"code": "D011635",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stephen Thomson",
"url": "https://questionsmedicales.fr/author/Stephen%20Thomson",
"affiliation": {
"@type": "Organization",
"name": "ANU College of Law, The Australian National University, Canberra, Australia. stephen.thomson@anu.edu.au."
}
},
{
"@type": "Person",
"name": "Muhammad Zia Ud Din",
"url": "https://questionsmedicales.fr/author/Muhammad%20Zia%20Ud%20Din",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China."
}
},
{
"@type": "Person",
"name": "Xu Yuan Yuan",
"url": "https://questionsmedicales.fr/author/Xu%20Yuan%20Yuan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. xuyuanyuanj@163.com."
}
},
{
"@type": "Person",
"name": "Naqib Ullah Khan",
"url": "https://questionsmedicales.fr/author/Naqib%20Ullah%20Khan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. naqibkhan05@csu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37264325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05736-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Placenta Accreta Spectrum.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37290094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005229"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physiology and Pathophysiology of the Placenta.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37240411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24109066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Preeclamptic Placenta in Whole Slide Images Using Artificial Intelligence Placenta Analysis.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39403751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2024.39.e271"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation of placental thickness and placenta percreta in patients with placenta previa: findings from MRI.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36114883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00261-022-03676-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Administration de la santé publique",
"item": "https://questionsmedicales.fr/mesh/D011635"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Administration de la santé publique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Administration de la santé publique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Administration de la santé publique",
"description": "Comment évaluer l'efficacité d'un programme de santé publique ?\nQuels outils sont utilisés pour le diagnostic en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Placenta#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Administration de la santé publique",
"description": "Quels symptômes indiquent un problème de santé publique ?\nComment les symptômes de maladies affectent-ils la santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Placenta#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Administration de la santé publique",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment la prévention est-elle mesurée ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Placenta#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Administration de la santé publique",
"description": "Quels traitements sont prioritaires en santé publique ?\nComment les traitements sont-ils administrés en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Placenta#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Administration de la santé publique",
"description": "Quelles complications peuvent survenir sans intervention en santé publique ?\nComment les complications affectent-elles les systèmes de santé ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Placenta#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Administration de la santé publique",
"description": "Quels sont les principaux facteurs de risque en santé publique ?\nComment identifier les facteurs de risque dans une population ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Placenta#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un programme de santé publique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic en santé publique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de santé publique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment les symptômes de maladies affectent-ils la santé publique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle mesurée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages."
}
},
{
"@type": "Question",
"name": "Quels traitements sont prioritaires en santé publique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils administrés en santé publique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans intervention en santé publique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles les systèmes de santé ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque en santé publique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque dans une population ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques, des enquêtes et des analyses de données démographiques."
}
}
]
}
]
}
Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, North Carolina (Dr Little); and North Carolina Health Care Facilities Association, Raleigh, North Carolina (Ms Welsh and Dr Sholar).
Publications dans "Administration de la santé publique" :
To evaluate the effect of placental location on the severity of placenta accreta spectrum (PAS)....
We analyzed 390 patients with placenta previa combined with placenta accreta spectrum who underwent cesarean section between January 1, 2014 and December 30, 2020 in the electronic case database of th...
The history of cesarean delivery rates in the anterior group (91.67%) and the non-central group (85.71%) were statistically different from the posterior group (63.74%)(P < 0.001). Univariate logistic ...
Compared with posterior placenta, anterior and non-central placenta are independent risk factors for invasive PAS in patients with placenta previa, during which we should be more cautious in treatment...
Placenta accreta spectrum (PAS) is one of the most dangerous conditions in pregnancy and is increasing in frequency. The risk of life-threatening bleeding is present throughout pregnancy but is partic...
Preeclampsia (PE) is a hypertensive pregnancy disorder linked to placental dysfunction, often involving pathological lesions like acute atherosis, decidual vasculopathy, accelerated villous maturation...
A total of 168 placental whole-slide images (WSIs) of patients from Seoul National University Hospital (comprising 84 PE cases and 84 normal controls) were used for model development and internal vali...
Using ensemble modeling, we developed a model to identify PE placentas. The model showed good performance (area under the precision-recall curve [AUPRC], 0.771; 95% confidence interval [CI], 0.752-0.7...
The proposed computational pathology model demonstrated a strong ability to identify preeclamptic placentas. Computational pathology has the potential to improve the identification of PE placentas....
This study aimed to identify if placental thickness measured from MRI images correlated with placenta percreta in patients with placenta previa....
Placental thickness was retrospectively measured in 161 patients from July 2018 to August 2020. The measurements were performed at the thickest part of the placenta in the lower uterine segment on the...
Placental thickness in patients with placenta percreta was significantly higher than in patients with placenta increta, placenta accreta, and normal placentas (p < 0.05). Multivariate analysis reveale...
Patients with placenta percreta had the highest placental thickness. Placental thickness was correlated with placenta percreta....
The objective of this study was to assess the performance of ultrasound and magnetic resonance imaging (MRI) features in helping to classify the type of placenta accreta spectrum (PAS; accreta/increta...
We conducted a retrospective study in 82 pregnant women with PAS who underwent ultrasound and MRI examination of the pelvis before delivery (from an initial cohort of 185 women with PAS). We estimated...
Among the 82 patients, 29 (35%) had placenta accreta/increta and 53 (65%) had placenta percreta. The best features to discriminate between placenta accreta/increta and placenta percreta with ultrasoun...
The nomogram we developed to predict the risk of placenta percreta among patients with PAS had good discriminative capabilities. This performance and its impact on maternal morbidity should be confirm...
Although historically pre-eclampsia, preterm birth, abruption, fetal growth restriction and stillbirth have been viewed as clinically distinct entities, a growing body of literature has demonstrated t...
Placental accreta spectrum (PAS) disorder with bladder involvement can be associated with maternal and neonatal morbidity. Magnetic resonance imaging (MRI) may provide accurate preoperative diagnoses....
This study had 2 aims: to retrospectively review the MRI findings for bladder involvement in PAS with placental previa and to correlate bladder involvement with maternal and neonatal outcomes....
MRI images of 48 patients with severe PAS (increta and percreta) with placenta previa/low-lying placenta were evaluated by 2 experienced radiologists blinded to the final diagnoses. Nine MRI findings ...
Of the 48 patients, 27 did not have bladder involvement, while 21 did. Logistic regression analysis identified 2 predictive MRI features for bladder involvement. They were abnormal vascularization (OR...
PAS with bladder involvement was significantly correlated with massive surgical blood loss. Prenatally, the disorder was predicted with high specificity by the combination of loss of chemical shift ar...
To determine the rate of resolution of placenta previa and low-lying placenta (LLP) and the effect of pelvic rest recommendations on the timing of follow-up imaging....
Retrospective review of pregnancies with previa/LLP detected on mid-trimester exam at our ultrasound unit from 2019 to 2021. LLP was defined as the lower edge of placenta located within 2 cm of the in...
Exactly 144 patients had previa and 266 had LLP on the mid-trimester exam with complete records. Previa resolution happened in 51.4% (74/144) of cases. Exactly 62% (46/74) of previa resolutions occurr...
Most societies recommend follow-up imaging at 32 weeks; however, our results suggest this may be done sooner and closer to 28 weeks. Pelvic rest did not affect timing of repeat imaging or delivery....
To determine whether women who experience resolution of low placentation (low-lying placenta or placenta previa) are at increased risk of postpartum hemorrhage compared to those with normal placentati...
This was a retrospective cohort study of women who delivered at Mount Sinai Hospital between 2015 and 2019, and who were diagnosed with low-lying placenta or placenta previa on transvaginal ultrasound...
A total of 1256 women were identified for analysis, of whom 628 had resolved low placentation and 628 had normal placentation. Women with resolved low placentation, compared to those with normal place...
Despite high rates of resolution of low-lying placenta and placenta previa by term, women with resolved low placentation remain at increased risk of postpartum hemorrhage compared to those with normal...
